menu

Exploring the Role of T Cells & OX40 Signaling in Atopic Dermatitis

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

From Heterogeneity Comes New Insights: Exploring the Role of T Cells & OX40 Signaling in Atopic Dermatitis

Details
Recommended

Overview

ReachMD Healthcare Image
RestartResume

Join us as we examine the OX40 pathway’s relevance to T-cell-driven inflammation in moderate-to-severe atopic dermatitis.

  • Sponsored by

  • Overview

    Atopic dermatitis is more than a disease of the skin. It’s a complex and heterogeneous inflammatory disease mediated by multiple T-cell–driven inflammatory pathways, like the OX40 pathway, leading to chronic and persistent symptoms and significant burden.1-4 Explore the heterogeneity of atopic dermatitis and the importance of OX40 signaling in disease pathogenesis with Dr Charles Turck and Dr. Jonathan Silverberg, Professor and Director of Clinical Research and the Director of Patch Testing at George Washington University School of Medicine and Health Sciences.

    References:

    1. Silverberg JI. Clinical Management of Atopic Dermatitis. 1st ed. 2018.
    2. Ratchataswan T, et al. J Allergy Clin Immunol Pract. 2021;9:1053-1065.
    3. Weidinger S, et al. Nat Rev Dis Primers. 2018;4:1.    
    4. De Bruyn Carlier T, et al. J Autoimmun. 2021;120:102634.

    ©2023 Amgen Inc. All rights reserved. USA-451-80031 8/23

Schedule12 Apr 2024